journal article·2025-12Open access

Y-shaped trivalent aptamer for targeted visualization and tracking of reprogrammed astrocytes

Bohyun Oh, Eun-Song Lee, Eun-Hye Lee, Kyung-Min Kim, Yeonju Lee, Jin-Sam Lee, Hong-Gyun Lee, Hyobin Jeong, Chang-Hwan Park, Young-Pil Kim

Abstract

Despite extensive research into the diverse transformations and functions of astrocytes, conventional fluorescence immunohistochemistry for their distinct identification remains challenging and time-consuming, primarily due to the lack of cell surface binders specific to these glial cells. To address this limitation, we developed a specific and straightforward imaging strategy for primary astrocytes using cell surface-targeting aptamers. We identified a novel anti-astrocyte DNA aptamer (designated Ast17-30) through a 17-round cell-SELEX process incorporating magnetic-activated cell sorting, designed to bypass the technical hurdles of SELEX when applied to short-lived cells. To enhance binding affinity, we further engineered this aptamer into a Y-shaped trimer (Tri-ΔAst17-30), enabling clear discrimination between astrocytes and neurons. Consequently, the engineered trivalent aptamer facilitated rapid astrocyte-specific endocytosis within minutes due to its increased binding avidity. This capability enabled longitudinal monitoring of astrocyte conversion into induced neural precursor cells, observing moderate pro-inflammatory gene expression in their transcriptomic profiles. Furthermore, Tri-ΔAst17-30 bound strongly to astrocytic glioblastoma cells (U87MG), with minimal binding to glial glioblastoma cells (C6), confirming specificity for astrocytic tumor cells. Given the current absence of reliable live-astrocyte-specific imaging techniques, we propose that this trivalent anti-astrocyte DNA aptamer has potential for investigating developmental pathways and targeted therapy of these crucial glial cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · CRISPR and Genetic Engineering · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Heterogeneity in astrocyte morphology and physiology10.1016/j.brainresrev.2009.12.001 ↗
2. Reactive astrocytes: production, function, and therapeutic potential10.1016/j.immuni.2017.06.006 ↗
3. The emerging nature of astrocyte diversity10.1146/annurev-neuro-070918-050443 ↗
4. Transdifferentiation: a new promise for neurodegenerative diseases10.1038/s41419-018-0891-4 ↗
5. Mechanisms of disease: astrocytes in neurodegenerative disease10.1038/ncpneuro0355 ↗
6. Astrocytes: emerging therapeutic targets in neurological disorders10.1016/j.molmed.2019.04.010 ↗
7. Purification of rat and mouse astrocytes by immunopanning10.1101/pdb.err080101 ↗
8. Improved tools to study astrocytes10.1038/s41583-020-0264-8 ↗
9. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice10.1002/cne.10552 ↗
10. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A ↗
11. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS10.1523/JNEUROSCI.0790-07.2007 ↗
12. Generation and characterization of brain lipid-binding protein promoter-based transgenic mouse models for the study of radial glia10.1002/glia.20274 ↗
13. Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-110.1002/glia.22322 ↗
14. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes10.1002/glia.23140 ↗
15. Localization of neuronal and glial glutamate transporters10.1016/0896-6273(94)90038-8 ↗
16. Development of DNA aptamers using Cell-SELEX10.1038/nprot.2010.66 ↗
17. Recent developments in cell-SELEX technology for aptamer selection10.1016/j.bbagen.2018.07.029 ↗
18. Recent progress in aptamer discoveries and modifications for therapeutic applications10.1021/acsami.0c05750 ↗
19. Aptamers as therapeutics10.1038/nrd3141 ↗
20. Aptamer-protein interactions: from regulation to biomolecular detection10.1021/acs.chemrev.3c00377 ↗
21. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer'S disease model10.1016/j.stem.2013.12.001 ↗
22. Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons10.1186/s40035-018-0132-x ↗
23. Direct conversion of astrocytes into neuronal cells by drug cocktail10.1038/cr.2015.120 ↗
24. Evolution of multivalent supramolecular assemblies of aptamers with target-defined spatial organization10.1038/s41565-025-01939-8 ↗
25. pH-responsive size-tunable self-assembled DNA dendrimers10.1002/anie.201205862 ↗
26. Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage10.1074/jbc.M114.629808 ↗
27. Astrocytes: glutamate producers for neurons10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N ↗
28. Beyond the role of glutamate as a neurotransmitter10.1038/nrn916 ↗
29. Glutamate-dependent neuroglial calcium signaling differs between young and adult brain10.1126/science.1226740 ↗
30. Radial glial cells: are they really glia?10.1016/S0896-6273(01)00437-8 ↗
31. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery
32. The appropriate marker for astrocytes: comparing the distribution and expression of three astrocytic markers in different mouse cerebral regions
33. SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions10.1523/JNEUROSCI.3199-16.2017 ↗
34. Astrocyte reactivity after brain injury-the role of galectins 1 and 310.1002/glia.22898 ↗
35. Extensive transcriptional and chromatin changes underlie astrocyte maturation in vivo and in culture10.1038/s41467-021-24624-5 ↗
36. Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging10.1172/jci.insight.144351 ↗
37. Neuronal activity induces glutathione metabolism gene expression in astrocytes10.1002/glia.23455 ↗
38. Conserved properties of dentate gyrus neurogenesis across postnatal development revealed by single-cell RNA sequencing10.1038/s41593-017-0056-2 ↗
39. A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum
40. Hedgehog: a key signaling in the development of the oligodendrocyte lineage10.3390/jdb4030028 ↗
41. A single-cell RNA sequencing study reveals cellular and molecular dynamics of the hippocampal neurogenic niche10.1016/j.celrep.2017.11.050 ↗
42. Transcription factor-based fate specification and forward programming for neural regeneration, Front10.3389/fncel.2020.00121 ↗
43. Olig1 expression pattern in neural cells during rat spinal cord development
44. Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior10.1038/s41380-021-01424-3 ↗
45. Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4 and PDPN CAFs to clinical outcome10.1038/s43018-020-0082-y ↗
46. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes10.1016/j.immuni.2018.11.004 ↗
47. Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors10.1523/JNEUROSCI.1256-12.2012 ↗
48. Co-stimulation with IL-1β and TNF-α induces an inflammatory reactive astrocyte phenotype with neurosupportive characteristics in a human pluripotent stem cell model system10.1038/s41598-019-53414-9 ↗
49. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience10.1038/nrn.2016.46 ↗
50. Optogenetic calcium modulation in astrocytes enhances post-stroke recovery in chronic capsular infarct10.1126/sciadv.adn7577 ↗
51. Uncovering astrocyte morphological dynamics using optical diffraction tomography and shape-based trajectory inference10.1002/adhm.202402960 ↗
52. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD1410.1002/glia.22657 ↗
53. Multifaceted role of CD14 in innate immunity and tissue homeostasis10.1016/j.cytogfr.2023.08.008 ↗
54. A distinct astrocyte subtype in the aging mouse brain characterized by impaired protein homeostasis10.1038/s43587-022-00257-1 ↗
55. Droplet-based forward genetic screening of astrocyte-microglia cross-talk10.1126/science.abq4822 ↗